Kenvue Inc.
Kenvue Inc. Announces 2024 Annual Meeting Voting Results
Summary
Kenvue Inc. held its 2024 Annual Meeting of Shareholders on May 23, 2024, where shareholders elected all 11 director nominees, approved the compensation of named executive officers on a non-binding advisory basis, approved a one-year frequency for future advisory votes on executive compensation, and ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2024.
Profitelligence Alerts
Get alerts for KVUE
Be first to know when Kenvue Inc. files with the SEC.
Filing Categories
Advertisement
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Official SEC Documents
Advertisement